Cingulate (CINGW) Operating Leases (2021 - 2026)
Cingulate's (CINGW) quarterly Operating Leases came in at $968455.0 in Q2 2026, down 11.98% quarter-over-quarter from $1.1 million in Q4 2025.
Analysis
Cingulate (CINGW) Operating Leases (2021 - 2026) Analysis & Trends
Cingulate (CINGW) has reported Operating Leases for 6 consecutive years, with $968455.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Operating Leases changed N/A year-over-year to $968455.0; the trailing twelve-month figure through Jun 2026 stood at $968455.0 (changed N/A YoY), and the FY2025 full-year result was $1.1 million, changed N/A from the prior year.
- Operating Leases slipped to $968455.0 in Q2 2026 per CINGW's latest filing, from $1.1 million in the prior quarter.
- Across five years, Operating Leases topped out at $1.2 million in Q3 2025 and bottomed at $33145.0 in Q1 2024.
- Historically, Operating Leases has averaged $568854.0 across 5 years, with a median of $533649.5 in 2022.
- The sharpest annual moves came in 2022 and 2024: Operating Leases sank 41.01% in 2022, then sank 91.83% in 2024.
- Over 5 years, Operating Leases stood at $488748.0 in 2022, then tumbled by 73.27% to $130663.0 in 2023, then plunged by 74.63% to $33145.0 in 2024, then soared by 3219.42% to $1.1 million in 2025, then dropped by 11.98% to $968455.0 in 2026.
- According to Business Quant data, Operating Leases over the past three periods registered $968455.0, $1.1 million, and $1.2 million for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 644.46 Bn | 623.70 Bn | 17.26 Bn |
| 2 | AbbVie | 440.11 Bn | 433.54 Bn | 12.70 Bn |
| 3 | Merck | 365.04 Bn | 357.90 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.82 Bn | 259.13 Bn | 11.24 Bn |
| 5 | Pfizer | 159.14 Bn | 147.45 Bn | 10.94 Bn |
| 6 | Sanofi | 52.47 Bn | 45.09 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 44.26 Bn | 44.26 Bn | - |
| 8 | Incyte | 25.32 Bn | 20.79 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.46 Bn | 18.80 Bn | 683.80 Mn |
| 10 | Cingulate | 100,214.03 | 100,214.03 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 968,455.00 |
| Dec 31, 2025 | 1.10 Mn |
| Sep 30, 2025 | 1.16 Mn |
| Mar 31, 2024 | 33,145.00 |
| Dec 31, 2023 | 130,663.00 |
| Sep 30, 2023 | 225,368.00 |
| Jun 30, 2023 | 317,343.00 |
| Mar 31, 2023 | 405,482.00 |
| Dec 31, 2022 | 488,748.00 |
| Sep 30, 2022 | 578,551.00 |
| Jun 30, 2022 | 665,842.00 |
| Mar 31, 2022 | 749,508.00 |
| Dec 31, 2021 | 828,503.00 |